Articles
Page 18 of 27
-
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P53
-
Aneuploidy-driven non-heritable genomic variations demonstrate area-specific distribution in the Alzheimer’s disease brain
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P52 -
Ataxia-telangiectasia paradoxes: spotlight on post-zygotic chromosome instability in the brain and its contribution to neurodegeneration pathways
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P51 -
Mechanism of tau transfer: insights from cell culture and animal models
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P50 -
Histone deacetylase inhibition leads to neuroprotection through regulation on glial function
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P49 -
Differential pathways for the interleukin-1β production activated by chromogranin A and Aβ in microglia
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P48 -
A driver or a passenger? D421-caspase cleaved tau is associated with aggregated and insoluble tau
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P47 -
Phosphorylation of hnRNP K controls cytosolic accumulation of TDP-43
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P46 -
Role of ROS in Aβ42 mediated cell surface P-selectin expression and actin polymerization
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P44 -
Cysteine-rich domain of scavenger receptor Al modulates the efficacy of surface targeting and mediates internalization of oligomeric beta amyloid
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P43 -
Exposure to the saturated free fatty acid palmitate alters microglia inflammatory response
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P42 -
β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P41 -
Bexarotene treatment does not clear β-Amyloid in an AD mouse model and Beagle dogs
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P40 -
Neuronal MHC-I display in T-cell mediated neurodegeneration
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P38 -
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O37 -
Analysis of the protein network of cholesterol homeostasis maintenance in a mouse model of Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P37 -
Harnessing endogenous pathways and metabolites to treat or prevent neurodegenerative disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O36 -
Identification of proteins potentially involved in the formation of Lafora bodies, a hallmark of Lafora disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P36 -
Abeta is prerequisite, but insufficient to cause tau phosphorylation in vivo: tau phosphorylation in APP mice by diabetes
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P35 -
Identifying dominant modifiers of mutant FUS toxicity in vivo
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O33 -
Peripheral inflammation increases PKR activation, Tau phosphorylation and amyloid β production in wild-type mice
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P32 -
Glutathion-S-Transferases (GSTs) and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P30 -
Identification of potent inhibitors of microtubule affinity regulating kinase for inhibition of tau hyperphosphorylation
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P28 -
Mechanisms of Aβ induced synaptic toxicity
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O26 -
Cytoprotective functions of amyloid precursor protein family members in stress signaling and aging
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P26 -
The transcription factor XBP-1 in neurodegenerative diseases
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O24 -
Regulation of Fe65 during neuronal differentiation
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P24 -
Secretases: potential and roadblocks on the way to therapy
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O22 -
FcgRIIb mediates amyloid-β neurotoxicity and memory impairment in a model of Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P22 -
Super-resolution fluorescence imaging of intracellular mutant huntingtin protein reveals a population of fibrillar aggregates co-existing with compact perinuclear inclusion bodies
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O18 -
Serum from Parkinson’s disease patients presents excess of protein halogenation and nitrosylation, with anomalous nitrosylation of serum α-synuclein as potentially etiological factor
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P18 -
Designing nanoparticles for delivery of neurotrophic proteins
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O16 -
Corynoxine isomers decrease levels of amyloid-β peptide and amyloid-β precursor protein by promoting autophagy and lysosome biogenesis
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P16 -
Altered expression of antioxidant enzymes and autophagic proteins in transglutaminase 2 knockout mice
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P15 -
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P14 -
The dishomeostasis of metal ions plays an important role for the cognitive impartment
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P13 -
Genetic analysis of neurodegeneration.. the end game
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O12 -
Using Caenorhabditis elegans to fight human neurodegenerative diseases
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P12 -
Posterior cortical atrophy: correlation between clinical, neuropsychological, magnetic resonance and positron emission tomography Imaging
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P11 -
Endogenous and exogenous regulation of gamma-secretase
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O10 -
The pro-neurotrophin receptor sortilin is a major neuronal APOE receptor for catabolism of amyloid-β peptide in the brain
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P10 -
CYP2E1 and Parkinson’s disease in a MPTP-induced C57BL/6 mouse model
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P9 -
Neurochemical changes in animal models of Parkinson’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P7 -
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O7 -
RAGE targeted strategies for Alzheimer’s amyloid β peptide induced blood brain barrier dysfunctions
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P5 -
The biological function of β-secretase
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O5 -
dld-1 suppression attenuates the detrimental effects of amyloid beta deposition in a Caenorhabditis elegansmodel of Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P3 -
Functional genetics – an approach to mechanisms in Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O3 -
Methylene blue decreases brain mitochondrial ABAD and amyloid beta levels protecting mitochondrial functions in LPS-mouse model
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P1 -
Decoding Alzheimer’s in the age of genome-wide analyses
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O1
Follow
- ISSN: 1750-1326 (electronic)